chr5-179820937-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 11P and 4B. PVS1PS1_ModeratePP5BS2
The NM_003900.5(SQSTM1):āc.1A>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,547,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003900.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SQSTM1 | NM_003900.5 | c.1A>G | p.Met1? | start_lost | 1/8 | ENST00000389805.9 | |
SQSTM1 | NM_001142298.2 | c.-47-2021A>G | intron_variant | ||||
SQSTM1 | NM_001142299.2 | c.-47-2021A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SQSTM1 | ENST00000389805.9 | c.1A>G | p.Met1? | start_lost | 1/8 | 1 | NM_003900.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152074Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.0000115 AC: 16AN: 1395912Hom.: 0 Cov.: 31 AF XY: 0.0000130 AC XY: 9AN XY: 691524
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152074Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 24, 2020 | The SQSTM1 c.1A>G (p.Met1?) variant disrupts the initiation codon and is predicted to interfere with normal protein expression. A different nucleotide change that also disrupts the initiation codon, c.2T>A, has been reported in a homozygous state in three siblings with childhood-onset neurodegeneration with ataxia, dystonia, gaze palsy and cognitive decline. Analysis of fibroblasts from affected individuals in this family, indicated the absence of any translated gene product (Haack et al. 2016). The c.1A>G variant is reported at a frequency of 0.000230 in the African/African-American population of the Genome Aggregation Database, which is based on two alleles in a region of good sequencing coverage. One additional allele affecting the initiation codon is also present in the Ashkenazi Jewish population. Based on the collective evidence, the c.1A>G variant is classified as likely pathogenic for childhood-onset neurodegeneration with ataxia, dystonia, and gaze palsy. - |
Paget disease of bone 2, early-onset;C5779877:Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 07, 2023 | Disruption of the initiator codon has been observed in individual(s) with autosomal recessive neurodegeneration with ataxia, dystonia, and gaze palsy (PMID: 27545679). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1019776). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change affects the initiator methionine of the SQSTM1 mRNA. The next in-frame methionine is located at codon 85. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 13, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at